The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An evaluation of local and systemic immune markers following intratumoral administration of a chimeric adenovirus Ad5/3-D24-GMCSF in refractory cancer patients with solid tumors.
 
Sari Anneli Pesonen
Employment - Oncos Therapeutics
Stock and Other Ownership Interests - Oncos Therapeutics
Patents, Royalties, Other Intellectual Property - Oncos Therapeutics
 
Tuuli Ranki
Employment - Oncos Therapeutics
Stock and Other Ownership Interests - Oncos Therapeutics
Patents, Royalties, Other Intellectual Property - Oncos Therapeutics
 
Elke Jäger
Consulting or Advisory Role - Oncos Therapeutics
Travel, Accommodations, Expenses - Oncos Therapeutics
 
Julia Karbach
No Relationships to Disclose
 
Claudia Wahle
No Relationships to Disclose
 
Timo K. Joensuu
No Relationships to Disclose
 
Tuomo Alanko
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Lilly; Pfizer; Roche Pharma AG
Expert Testimony - Bayer; Nordic Group; Teva
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Celgene; Pierre Fabre
 
Kaarina Partanen
Research Funding - Docrates Cancer Center
 
Kalevi Kairemo
Consulting or Advisory Role - Bayer Schering Pharma
 
Riku Turkki
No Relationships to Disclose
 
Nina Linder
No Relationships to Disclose
 
Johan Lundin
Research Funding - Pfizer (Inst); Roche Pharma AG (Inst)
Patents, Royalties, Other Intellectual Property - Fimmic Oy
 
Ari Ristimäki
No Relationships to Disclose
 
Mamun Majumder
Research Funding - Celgene (Inst)
 
Ashwini Kumar
Research Funding - Celgene (Inst)
 
Caroline Heckman
Research Funding - Celgene (Inst)
 
Matti Kankainen
No Relationships to Disclose
 
Akseli Hemminki
Employment - TILT Biotherapeutics
Stock and Other Ownership Interests - Oncos Therapeutics; TILT Biotherapeutics
Consulting or Advisory Role - Amgen
Research Funding - Oncos Therapeutics (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Mikael Von Euler
Employment - KDev Oncology
Leadership - Akinion; Axelar; KDev Oncology
Stock and Other Ownership Interests - Roche
Consulting or Advisory Role - Akinion (Inst); Aprea AB (Inst); Axelar (Inst); Oncos Therapeutics
 
Magnus Erik Jaderberg
Employment - Oncos Therapeutics
Leadership - Oncos Therapeutics
Stock and Other Ownership Interests - Bristol-Myers Squibb